GlassScriptPhysician profile
Ann M Powelson
NPI 1619356524
$3,711.79
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.30 · 2020: $552 · 2021: $686 · 2022: $2,063 · 2023: $260 · 2024: $93.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,361.56 | 2022-2024 | Da Vinci Surgical System |
| Abbvie INC. | $627.76 | 2019-2021 | |
| Therapeuticsmd, INC. | $163.21 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $86.37 | 2020-2021 | |
| Daiichi Sankyo INC. | $82.44 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.81 | 2020 | |
| Minerva Surgical, INC | $57.74 | 2021 | |
| Myriad Women'S Health, INC. | $56.07 | 2023 | Myrisk |
| Myovant Sciences INC. | $48.84 | 2021 | |
| Hologic Sales and Service, LLC | $37.98 | 2020-2021 | |
| Organon LLC | $29.64 | 2021 | |
| Coloplast Corp | $19.60 | 2021 | |
| Pfizer INC. | $19.47 | 2020 | |
| Mylan Pharmaceuticals INC. | $18.68 | 2021 | |
| Amag Pharmaceuticals, INC. | $15.82 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Powelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.